Ryan is an experienced healthcare executive in the pharmaceutical and medical device industries. He has a passion for investing in disruptive healthcare technologies to bring about meaningful improvement to patients, providers, and systems.
He is the founder of Brooks Management Group, a healthcare venture capital firm. Ryan currently serves on the board of CenExel Clinical Research, a pharmaceutical and medical device clinical site network. Previously, he has worked for several startups and blue-chip companies Eli Lilly & Company, Boston Scientific Corporation, St. Jude Medical, and Abbott Laboratories. Ryan has experience in the development and execution of commercialization strategies to drive the adoption of new technologies in healthcare.
Ryan earned his undergraduate degree from Brigham Young University and an MBA from Gonzaga University.